Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)
🇪🇸 Spain Applicant Guide 2025
Quick Facts for Spain Applicants
Ready to Apply from Spain?
Get a personalized assessment tailored for Spain applicants
See in 5 min if your Spain organization qualifies for €80.0M funding💰 Funding Details
Funding Description
Overview
HORIZON-HLTH-2025-01-DISEASE-06 is a single-stage *Research & Innovation Action (RIA)* offering up to €80 million per project for implementation research that strengthens health systems to deliver equitable, high-quality care for non-communicable diseases (NCDs). The call is launched under the *Global Alliance for Chronic Diseases (GACD)* umbrella and aligns with the Horizon Europe destination “Tackling diseases and reducing disease burden.”
What the EU Wants
1. Evidence-backed health-system interventions that can be *adapted* and *scaled* in low- and middle-income settings or in disadvantaged populations of high-income settings.
2. Concrete implementation research (not basic efficacy trials) using validated frameworks (e.g. CFIR, RE-AIM, PRISM, Hybrid I–III designs).
3. Explicit focus on equity & Universal Health Coverage (UHC)—sex/gender analysis is mandatory; intersectionality strongly encouraged.
4. Stakeholder co-creation with policymakers, communities, patients and carers from *ideation* to *knowledge translation*.
5. Multidisciplinary, shared-leadership consortia that demonstrate fair HIC–LMIC governance and capacity-building for early-career researchers.
Financial Highlights
| Item | Detail |
| --- | --- |
| Max EU contribution | €80 000 000 per grant |
| Funding rate | 100 % of eligible direct costs + 25 % indirect costs |
| Project length | 3–6 years typical for GACD RIAs |
| Opening | 22 May 2025 |
| Deadline | 16 Sep 2025, 17:00 Brussels time |
Geographic Eligibility
• Legal entities from EU Member States, Horizon-Europe Associated Countries, and specifically LMIC partners are *eligible for funding*.
• Entities from the USA can be funded in reciprocity.
• Always verify national co-funding via your NCP in your country.
Why Apply from your country?
* Leverage your country's established primary-care network and digital-health startups.
* Showcase your country research institutions’ expertise in implementation science and health equity.
* Position your country as a key player in global NCD policy dialogues.
🇪🇸Spain Overview
🏷️ Keywords
Related Opportunities for Spain
Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
Tackling high-burden for patients and under-researched medical conditions
Ready to Apply from Spain?
Get a personalized assessment tailored for Spain applicants
See if your Spain organization qualifies for €80.0M fundingFrequently Asked Questions
Common questions about Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD) for Spain applicants